Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Ion semiconductor sequencing Stories

2014-01-09 04:20:58

CARLSBAD, Calif., Jan. 9, 2014 /PRNewswire/ -- Life Technologies (NASDAQ: LIFE) has completed a multi-year license and supply agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, that gives Quest rights to develop molecular tests on the Ion Torrent(TM) next-generation sequencing platform. Under the agreement, Quest may use the platform and related consumables to independently develop new tests for numerous areas of their...

2013-12-20 08:25:28

With more than 30 members the program is the largest network of next generation-based exome sequencing providers in the world CARLSBAD, Calif., Dec. 20, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that five new American, five European and two Asia Pacific sites joined the Ion AmpliSeq(TM) Exome Certified Service Provider program. Within three months of the program's launch, it's become the world's largest network of next generation-based sequencing...

2013-10-22 16:24:53

First author and winning paper honored for increasing understanding of intestinal immune system at Ion World 2013 CARLSBAD, Calif., Oct. 22, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced the inaugural Ion Torrent(TM) Breakthrough Award 2013 winner. The winning publication is "Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota," published in the May 2013 edition of Nature. The paper's first author, Ms. Anna...

2013-10-22 08:32:50

Ion Torrent customers will get cutting-edge solutions through company's new Technology Access Program CARLSBAD, Calif., Oct. 22, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it has launched two breakthrough technologies under its new Ion Torrent Technology Access Program (TAP), an initiative designed to foster collaboration with the scientific community and drive innovation. Customers can get access to the Ion Hi-Q(TM) Sequencing Chemistry and...

2013-10-21 08:29:13

-- World's largest genome center to purchase 50 Ion Proton(TM) Sequencers from Life Technologies-- CARLSBAD, Calif., Oct. 21, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) and BGI, the world's largest genomics center and service provider, jointly announced that BGI has purchased 37 Ion Proton(TM) Sequencers and plans to add at least a dozen more by the end of the year, strengthening the organization's leadership position in the genomics industry. BGI also signed a...

2013-10-09 08:26:37

Global scientists at the Ion Torrent(TM) annual conference present discoveries and genomic applications enabled by its next-generation sequencing solutions CARLSBAD, Calif., Oct. 9, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) welcomes scientists and students to attend the 2(nd) annual Ion World 2013 next-generation sequencing conference, Oct. 20-21, in Boston, MA preceding the American Society of Human Genetics (ASHG) conference. Scientists from around the world will...

2013-10-08 08:28:47

CARLSBAD, Calif., Oct. 8, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announces that, due to increased demand for Ion AmpliSeq(TM) exome sequencing, the Ion AmpliSeq(TM) Exome Certified Service Provider program, an organization of some of the world's top service providers that sequence and analyze human exomes, is expanding with 11 new members. Using the Ion AmpliSeq(TM) Exome Kit, the Ion Proton(TM) Sequencer, and the Ion Reporter(TM) Software, service providers...

2013-09-24 08:30:21

Guangzhou-based startup chooses Ion Torrent for superior speed and flexibility CARLSBAD, Calif., Sept. 24, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that iGenomics, a privately held diagnostic service company based in Guangzhou, China, purchased 17 Ion Proton(TM) sequencers and plans to add 15 more instruments by the end of the year. iGenomics, which also signed a licensing and supply agreement with Life Technologies, will initially use the...

2013-09-16 23:02:40

Illumina has the most prevalent model of sequencer in a worldwide survey of labs performing sequencing, according to a recent Kalorama Information survey. The healthcare market research publisher said Illumina’s MiSeq is the most popular individual sequencer model, though Life Technologies’ systems of all models are still the most commonly found in labs overall. New York, NY (PRWEB) September 16, 2013 Illumina has the most prevalent model of sequencer in a worldwide survey of labs...

2013-09-10 08:29:15

CARLSBAD, Calif., Sept. 10, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announces the Ion AmpliSeq(TM) Exome Certified Service Provider program, a global organization of some of the world's top service providers that will sequence and analyze human exomes in as little as two days. Sequencing requires just 50 ng of DNA and is very competitively priced, making exome sequencing accessible to any researcher. Until now, exome sequencing through a service provider has...